Evidence map›Paper›PMID 41726655›Full record

ArticleACS omega2026

Differential Effects of Various Alkyl Citrate Esters and Inorganic Citrate Salts on Calcium Oxalate Crystal Dissolution and Renal Cell Viability.

Samuel Drawbridge, Rattiyaporn Kanlaya, Visith Thongboonkerd

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samuel DrawbridgeGraduate Program in Pharmacology, Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Rattiyaporn KanlayaMedical Proteomics Unit, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10400, Thailand.
Visith ThongboonkerdMedical Proteomics Unit, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10400, Thailand.ORCID https://orcid.org/0000-0001-7865-0765

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney stone disease (KSD) is a worldwide social and economic burden. Potassium citrate (KCitrate) has been used for preventing KSD recurrence, but many patients develop gastrointestinal symptoms and subsequently discontinue therapy. Alkyl citrate esters have been thought to be safer but with no clear evidence of their efficacy and renal toxicity. This study compared the dissolution efficacies of various alkyl citrate esters (trimethyl citrate or TMC, triethyl citrate or TEC, and isopropyl citrate or IPC) and inorganic citrate salts (NaCitrate, KCitrate, and MgCitrate) on calcium oxalate monohydrate (COM) crystals and their cytotoxic effects on renal cells. At 50 mM (utilizing KCl and EDTA as negative and positive controls, respectively), IPC was the most effective alkyl citrate ester, whereas NaCitrate and KCitrate were the most effective inorganic citrate salts to dissolve COM crystals. These potent compounds were further investigated, whereas others with much fewer dissolution effects were not pursued. Cytotoxic analysis of the three most potent citrate forms revealed that NaCitrate and KCitrate at ≤12.5 mM did not affect renal cell viability, whereas IPC showed obvious cytotoxic effects at all concentrations tested. A time-course study utilizing a nontoxic concentration (12.5 mM) revealed that both NaCitrate and KCitrate reduced COM crystal size to less than a quarter at the end of the assay. Their dissolution capability was confirmed by measuring [Ca

Identifiers

PMID41726655
PMCPMC12917706

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.